10 (Suppl B): S5762
Examples include: peptide therapy (at high doses or long-term use) TB-500 (Thymosin Beta-4) VEGF-mimetic peptides Tesamorelin/peptide therapy (via IGF-1 pathways) Potential risks of prolonged use: Scar tissue overdevelopment Feeding abnormal or cancerous cell growth Disrupting blood flow in sensitive tissues (eyes, kidneys) Thats why we recommend cycles like: TB-500 : 610 weeks on, 4+ weeks off peptide therapy injections : short-term, with oral BPC for maintenance Tesamorelin/peptide therapy : rotated or paused to avoid overexposure Other Peptides That Benefit From Cycling Even non-angiogenic peptides benefit from breaks: Thymosin Alpha-1 : 5-week cycles, 23x per year GHK-Cu : 78 week cycles, followed by rest Semax & Dihexa : pulsed use to maintain brain sensitivity 5-Amino-1MQ : cycled after 23 rounds for metabolic reset Each protocol is tailored to half-life, tissue targets, and sensitivity feedback
After reconstitution, the vial goes straight into the refrigerator
Through a randomized, double-blind, placebo-controlled trial involving 20 pediatric T1D patients, Reddi et al
AOD-9604 works best when paired with a healthy diet and exercise
By purchasing this product, the buyer confirms they are a qualified researcher or authorised institution and agrees to handle, store, and use the material in accordance with all applicable laws, regulations, and established laboratory safety protocols
